STATE STREET CORP

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 93751 BOSTON, MA

Position in INO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$515,579

+$85,086 QoQ

Shares Held

296,310

+19.8% QoQ

Ownership

0.360%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 62.03435591103912.ToString("F0")% Shared 0.ToString("F0")% None 37.965644088960886.ToString("F0")%

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. INO ranks #297 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$515,579	296,310	+19.8%	Shares	Defined	2026-05-15
2025-12-31	$430,493	247,410	+32.9%	Shares	Defined	2026-02-13
2025-09-30	$435,731	186,210	+50.6%	Shares	Defined	2025-11-14
2025-06-30	$252,164	123,610	-76.0%	Shares	Defined	2025-08-14
2025-03-31	$838,061	514,148	+2.0%	Shares	Defined	2025-05-15
2024-12-31	$922,883	504,308	+2.8%	Shares	Defined	2025-02-14
2024-09-30	$2,836,026	490,662	+11.7%	Shares	Defined	2024-11-14
2024-06-30	$3,549,123	439,248	+395.3%	Shares	Defined	2024-08-14
2024-03-31	$1,230,892	88,681	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.